Inici › Tumors cerebrals › Texas › Houston
Assaigs clínics de Tumors cerebrals a Houston, TX
35 estudis de Tumors cerebrals busquen participants en centres de Houston i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
ReclutantFase 1
- Baylor St. Luke's Medical Center, Houston
Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
ReclutantFase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
ReclutantFase 2
- M D Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
ReclutantFase 1/2
- MD Anderson Cancer Center, Houston
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
ReclutantFase 2
- Local Institution - 0085, Houston
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
ReclutantFase 2
- Texas Children's Hospital, Houston
OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
ReclutantFase 1
- MD Anderson Cancer Center, Houston
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
ReclutantEstudi observacional
- M D Anderson Cancer Center, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutantFase 1
- MD Anderson Cancer Center - University of Texas, Houston
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
ReclutantEstudi observacional
- MD Anderson Cancer Center, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
ReclutantFase 1/2
- University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
ReclutantEstudi observacional
- Texas Children's Hospital, Houston
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
ReclutantFase 2
- UT MD Anderson Cancer Center, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
ReclutantFase 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
ReclutantFase 2
- Texas Children's Hospital, Houston
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
ReclutantFase 2
- MD Anderson Cancer Center, Houston
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
ReclutantFase 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
ReclutantFase 2
- Houston Methodist Neal Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
ReclutantFase 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
ReclutantFase 1
- Texas Children's Hospital, Houston
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
ReclutantEstudi observacional
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
ReclutantFase 1
- M D Anderson Cancer Center, Houston
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
ReclutantFase 2
- M D Anderson Cancer Center, Houston
Mapping of Human Cognition
Reclutant
- The University of Texas Health Science Center at Houston, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
ReclutantFase 2
- Texas Children's Hospital, Houston
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Reclutant
- M D Anderson Cancer Center, Houston
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
ReclutantEstudi observacional
- M D Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
ReclutantFase 2
- M D Anderson Cancer Center, Houston
EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
ReclutantFase 2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ReclutantFase 1/2
- MD Anderson Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
ReclutantEstudi observacional
- Md Anderson Cancer Center, Houston
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
ReclutantFase 2
- M D Anderson Cancer Center, Houston
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
Reclutant
- MD Anderson Cancer Center, Houston
Systematic Light Exposure in Pediatric Brain Tumor Survivors
Reclutant
- Texas Children's Hospital, Houston
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
ReclutantFase 1/2
- MD Anderson, Houston
Assaigs de Tumors cerebrals en altres ciutats
- Boston, MA28 estudis
- New York City, NY25 estudis
- Washington, DC20 estudis
- Los Angeles, CA16 estudis
- Miami, FL15 estudis
- Durham, NC14 estudis
- St. Louis, MO12 estudis
- Cleveland, OH11 estudis
- Seattle, WA11 estudis
- Rochester, MN11 estudis
- Baltimore, MD11 estudis
- Columbus, OH11 estudis
Altres estudis a Houston
- Càncer de pulmó de cèl·lules no petites145 estudis
- Càncer de mama126 estudis
- Càncer (tots els tipus)121 estudis
- Càncer metastàtic104 estudis
- Càncer colorrectal102 estudis
- Càncer d'ovari89 estudis
- Leucèmia mieloide aguda85 estudis
- Càncer de pulmó78 estudis
- Càncer de pròstata76 estudis
- Càncer d'endometri68 estudis
- Càncer de pàncrees61 estudis
- Melanoma59 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.